President Trump's Operation Warp Speed, with its promise of a coronavirus vaccine by the end of the year, is a lofty goal. To me, it is cruel. Only a vaccine can put an end to the virus' grip on our world. To make this promise on that timeline is obviously just a political move. For those of us who are older than 60 years, have children we haven't seen in two months and are afraid to leave our houses, this may really be the ultimate hoax.
Responding to the letter about Democrats in cities doing nothing for minorities for decades, it is by design. The Democrats do not want a vibrant, well-educated middle class. They want dependency on government that breeds a steady stream of voters. If someone becomes dependent on no one, they become mobile and can vote with their feet, and leave the Democrat control of their lives. Democrats want you dependent on them, thats the bottom line.
American democracy has been chained by the right and hijacked by the left. Middle America has been hoodwinked by upper-class elitists on both sides. Right-wing conservatives led by the top 2% super-rich have snookered the working class into believing that there is no difference between economic, religious or cultural conservative idealism. Left-wing academic, artsy and so-called progressive elitists have teamed with the media creating a massively profitable industrial complex feeding off the latest righteous crusades. The elites continue enriching themselves at the middles expense. Dont let the elites on either side crush our backbone. Stand up and fight for Middle America.
Independent Patriot
A Black national anthem and a white national anthem to be played at the start of the National Football Leagues first game? Really? This will do nothing but emphasize our differences rather than promote togetherness. I want an anthem that points out our weaknesses but yet strives for greatness. I want an anthem that explains fighting for the right to make all men equal not just in an hour of need but always. I want an anthem I can appreciate, that speaks for everyone, that all people would be proud to stand for.
After cancellation by the American Legion, it is inspiring to see the teams find a way to still play ball. They applied good old American ingenuity have a problem, find a way to fix it. They have banded together to play 33 games. There will be those who disapprove but what could be safer than healthy young men playing ball in the fresh air. Good luck to the Berks Independent Baseball League.
Proud to be an American
Seniors don't forget what you were promised from those you elected. They lied, you are still paying property taxes and you will lose your home. Make your vote count.
Night light
President Obama acknowledged on multiple occasions that he did not have the authority to unilaterally alter immigration law, yet its exactly what he did when he implemented DACA. At some point the courts will rightfully rule DACA unconstitutional as it did with DAPA. Its heartbreaking that the Democrats in Congress refused a very fair deal from President Trump in 2018 to resolve the fate of the Dreamers in exchange for increased border security and real immigration reform. President Trump has been trying to solve the problem, but the Democrats chose to leave the Dreamers in legal limbo just to have a campaign issue.
Robert Minninger
Thank you, Pottstown for having peaceful protests. Some questions for the white folks participating. Do you live in Pottstown? If not, why not? If you do live in Pottstown, what part of town do you live in and why did you choose it? Is it racially diverse? If you're protesting for equality yet going back to your all-white, no-crime neighborhood, you're a hypocrite.
Truth hurts
The inadequate response to the coronavirus in the Oval Office as well as similar actions by governors in states such as Alabama, Arizona, Arkansas and South Carolina (states with the highest rates in the nation when adjusted for population) have increased the coronavirus spread. Wear a mask. Stay safe!
M. Furlong needs to stop playing the name game in order to divert attention from the real issue of racial inequality in this country. The poor use of funds to help people of color can be blamed on both Democrats and Republicans since forever. And until he takes one small step toward impartiality, hell never understand the meaning of Black Lives Matter.
If you havent heard already, Tower Health is closing the Maternity Unit at Pottstown Hospital. The Maternity Unit has provided this community with outstanding care for mothers and their newborns and has provided a multitude of services like birthing classes, baby care classes, breastfeeding classes, car seat checks. Where will these girls go to deliver? Most of them dont have transportation to Reading or Phoenixville. This community is losing a great asset. We all need to contact the hospital, state and local reps and demand they keep this unit open. We need to keep our moms to be and babies safe!
This week's Stay-At-Home readings are: How To Avoid Traffic Tickets by Constance Lee Parks; How To Find Love by Mary Mee; Housecleaning Tips by Mary Maids; Positive Thinking by Will Power
Funnyman
The potential for "One-shot cures" of gene therapy is valid, however, such treatments do not offer recurring revenue like chronic therapies do. While gene therapy is very attractive to patients, it becomes a challenge to doctors of genome medicine looking for sustained cash flow. This should tell you what is most important and which path they'll follow since prescription drugs have made Big Pharma and docs quite wealthy.
Med Tech
Why are school police out and about in district cars when school isnt in session?
Ano Nymous
Should Rep. Houlahan be judged by the company she keeps? Disdain for the military is not a recent Democrat position. To mask this reality in historically Republican districts, Nancy Pelosi recruited former officers for 2018 congressional campaigns. One such candidate was Chrissy Houlahan who became a reliable ally of Rep. Adam Schiff (D-CA) in a seditious, fact-bereft attempt to unseat a president. Last week, Houlahan featured Rep. Karen Bass (D-CA) in a virtual town hall meeting. Who is Bass? An unapologetic radical who lamented the death of "Commandante El Jefe" Fidel Castro.
M. Furlong
Schools do not teach manners, that is the parents' job. What we see today are children with knowledge, sports achievements, different dress codes, anger over everything but no manners or common sense. You, as parents, have failed the youth of today and tomorrow. When an officer of the law says stop, why do children keep running?
Star Light
I'm so glad I got to see Mount Rushmore on television this past weekend because the way things are going, that will be the next thing the protesters want torn down.
I watched the amateur looters on the news dressed in T-shirts and shorts, but the professional looters who steal from us daily dress in suits and ties. They're known as "Congress!"
Jim Fitch
Sound Off is a forum to spur dialogue from residents of the communities The Mercury serves on topics of general interest in those communities and beyond. We will not publish comments that are potentially libelous, slanderous, mean-spirited, vulgar or inappropriate. Publication of Sound Off comments is at the sole discretion of the editor. Email your brief comment to letters@pottsmerc.com. Please use "Sound Off" in the subject line of the email.
See the original post here:
The Mercury's Sound Off for Sunday, July 12 | Opinion - The Mercury
- Unraveling The Complexity Of Cell Therapy: Advancements And Challenges - Life Science Leader Magazine - November 27th, 2024
- Novartis wagers more than $1B on gene therapies for the nervous system - BioPharma Dive - November 27th, 2024
- Gene therapy for geographic atrophy in age-related macular degeneration: current insights - Nature.com - November 27th, 2024
- Novartis buys gene therapy startup Kate Therapeutics, joining pursuit of muscular dystrophy treatment - STAT - November 27th, 2024
- At MGB's gene therapy institute, effort to win first venture capital investments continues - The Business Journals - November 27th, 2024
- Neurogene reports death of Rett patient left in critical condition by high dose of gene therapy - Fierce Biotech - November 27th, 2024
- Alzheimer Disease Awareness Month 2024: Looking Back at a Year of Progress in Cell and Gene Therapy - CGTLive - November 27th, 2024
- Why This Gene-Therapy Companys Stock Is Rising 228% - Yahoo! Voices - November 27th, 2024
- How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando - geneonline - November 27th, 2024
- RNA editing is the next frontier in gene therapy heres what you need to know - The Conversation - November 27th, 2024
- Assessment of gene therapy viral vectors in RPE cells - News-Medical.Net - November 27th, 2024
- Retinal organoids and RPE models for retinal gene therapy development - News-Medical.Net - November 27th, 2024
- China Vows to Bolster Gene Therapy Research in Key Biotech Hub - Bloomberg - November 27th, 2024
- Gene Therapy - Volume 31 Issue 11-12, November 2024 - Nature.com - November 27th, 2024
- Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer - GlobeNewswire - November 27th, 2024
- Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose - MedCity News - November 27th, 2024
- New CRISPR system pauses genes, rather than turning them off permanently - Livescience.com - November 27th, 2024
- Liver-targeting gene therapy lowers mice whole-body SMA symptoms - SMA News Today - November 27th, 2024
- Bright breakthroughs: Real stories of beating rare disease - Science - November 27th, 2024
- Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA... - November 27th, 2024
- A Year of DMD Gene Therapy Trial Failures - AJMC.com Managed Markets Network - November 3rd, 2024
- Hemophilia B: Gene Therapy Shows Promise - Medscape - November 3rd, 2024
- Around the Helix: Cell and Gene Therapy Company Updates October 30, 2024 - CGTLive - November 3rd, 2024
- 2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - PharmaVoice - November 3rd, 2024
- Cell therapy weekly: support for commercialization of complex therapies - RegMedNet - November 3rd, 2024
- Lexeo shares early data on Alzheimers gene therapy - Endpoints News - November 3rd, 2024
- Medicaid Aiming to Improve Patient Access to High-Cost Therapies - AJMC.com Managed Markets Network - November 3rd, 2024
- The Significance of Gene Therapy in Neuromuscular Medicine at the 2025 MDA Conference: Paul Melmeyer, MPP - Neurology Live - November 3rd, 2024
- OHSU researchers identify gene that could be key to future HIV vaccine - OHSU News - November 3rd, 2024
- Purespring gene therapy reduces kidney scarring in mice and is stably expressed in pigs - Fierce Biotech - November 3rd, 2024
- Data Roundup: October 2024 Features Update for TCR-Based Autologous Cell Therapy in Melanoma, the First Clinical Demonstration of Therapeutic RNA... - November 3rd, 2024
- NewBiologix Launches Xcell to Accelerate, Optimize, and Scale Gene and Cell Therapy Production - Business Wire - November 3rd, 2024
- Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy: the 200 Best Inventions of 2024 - TIME - November 3rd, 2024
- Addressing gene and cell therapy commercialization challenges - TechTarget - November 3rd, 2024
- University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first - The Business Journals - November 3rd, 2024
- Roche will aim to tackle gene therapy challenges through Dyno deal - The Pharma Letter - November 3rd, 2024
- Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into Real Medicines - Inside Precision Medicine - November 3rd, 2024
- Terumo automates manufacturing to expand cell & gene therapies - European Pharmaceutical Manufacturer - November 3rd, 2024
- 12-Year-Old Leaves Washington DC Hospital As The First Patient To Receive Approved Gene Therapy For Sickle Cell Disease - AfroTech - November 3rd, 2024
- Lexeo Therapeutics Announces Positive Interim Data for - GlobeNewswire - November 3rd, 2024
- New FDA designations granted to NCATS for rare disease therapies. - NCBI - October 22nd, 2024
- $1.8 Million Awarded to Study the Durability of Gene Therapy - University of Arkansas Newswire - October 22nd, 2024
- By the numbers: US leads charge of cell and gene therapies - BioWorld Online - October 22nd, 2024
- University of Arkansas Researcher Awarded $1.8M for Gene Therapy Study - Arkansas Business - October 22nd, 2024
- Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress - StockTitan - October 22nd, 2024
- Around the Helix: Cell and Gene Therapy Company Updates October 16, 2024 - CGTLive - October 22nd, 2024
- Japan mulls ways to boost cell, gene therapy approvals - BioWorld Online - October 22nd, 2024
- A New Type of Gene Therapy Shows Promise for Treating Retinitis Pigmentosa - Managed Healthcare Executive - October 22nd, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - Part 2 - BioPharm International - October 22nd, 2024
- When a Miracle Cure Is Left on the Shelf - Bloomberg - October 22nd, 2024
- Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31 - Business Wire - October 22nd, 2024
- MeiraGTx's gene therapy improves motor function and quality of life in phase 2 Parkinson's trial - Fierce Biotech - October 22nd, 2024
- 5 Sickle Cell Therapies to Watch Following Pfizers Oxbryta Exit - BioSpace - October 22nd, 2024
- Fiocruz and GEMMABio announce partnership for the development of gene therapies - Fiocruz - October 22nd, 2024
- JPMA on Japans Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List -... - October 22nd, 2024
- Cell and Gene Therapy Clinical Trial Market is expected to reach USD 119.3 Billion by 2032 at a 24.9% of CAGR - PharmiWeb.com - October 22nd, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - Part 3 - Pharmaceutical Technology Magazine - October 22nd, 2024
- The role of quality assurance in accelerating drug development for emerging therapies - pharmaphorum - October 22nd, 2024
- Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress - The Manila Times - October 22nd, 2024
- Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market is projected to grow at a CAGR of - PharmiWeb.com - October 22nd, 2024
- Gene therapy: advances, challenges and perspectives - PMC - October 6th, 2024
- Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges - BioSpace - October 6th, 2024
- Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow - FiercePharma - October 6th, 2024
- Meet Boston's National STEM Champion who's a junior in high school studying gene therapy - CBS Boston - October 6th, 2024
- Gene therapy research offers hope for kids with life-altering condition - WCVB Boston - October 6th, 2024
- Is gene therapy the next big step in vision loss treatment? - Medical News Today - October 6th, 2024
- Protein's Role in Insulin Signaling Could Have Implications for Gene Therapy - AJMC.com Managed Markets Network - October 6th, 2024
- Scientists overcome major challenge in gene therapy and drug delivery - News-Medical.Net - October 6th, 2024
- Innovative gene therapy for hemophilia - healthcare-in-europe.com - October 6th, 2024
- The Largest Network of Research Sites Vetted to Execute Complexities of Cell & Gene Therapy (CGT) Trials Now Includes 1,500 Sites - PR Newswire - October 6th, 2024
- Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now - Quartz - October 6th, 2024
- Cell therapy weekly: Promising Phase I results for Parkinsons disease cell therapy - RegMedNet - October 6th, 2024
- Targeting CREB-binding protein (CBP) abrogates colorectal cancer stemness through epigenetic regulation of C-MYC - Nature.com - October 6th, 2024
- Forge Biologics Announces the FUEL AAV Manufacturing Platform to Provide Developers with a More Efficient Solution for Gene Therapy Production -... - October 6th, 2024
- Ninth Circuit Decision Marks Critical Legal Victory for U.S. FDA in Mission to Protect Patients from Unregulated Cell Therapy Products - PR Newswire - October 6th, 2024
- Gene therapy: What is it and how does it work? | Live Science - September 21st, 2024
- How Does Gene Therapy Work? Types, Uses, Safety - Healthline - September 21st, 2024
- In race to make gene therapy for age-related blindness, 4D Molecular announces positive results - STAT - September 21st, 2024
- Penn gene therapy pioneer Jim Wilson explains why he's leaving - The Business Journals - September 21st, 2024
- Whats the Meaning of Cure in Gene Therapy? - Managed Healthcare Executive - September 21st, 2024